建滔積層板(01888.HK)中期歸母純利減少44%至18.74億港元 中期息15.0港仙
格隆匯8月29日丨建滔積層板(01888.HK)發佈公吿,截至2022年6月30日止六個月,公司營業額131.76億港元,同比減少5%;公司持有人應占基本純利18.74億港元,同比減少44%;每股基本盈利60.1港仙,每股中期股息15.0港仙。
由於覆銅面板及其上游物料於去年持續供不應求,大量業界同行都進行了不同程度的擴產從而大幅增加市場供應。但於回顧期內地緣政治衝突包括俄烏戰爭、國內疫情反覆尤其是上海疫情、以及全球高通脹持續,對電子行業產生了較大的負面影響,集團期內覆銅面板的銷量及單價均錄得下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.